Previously, five strategies have been proposed to prolong the survival of ecDNA-related cancer patients18, which highlights the translational potential of ecDNA, for instance, through targeting ecDNA clustering into hubs with the BET protein BRD411 to reduce the risk of ecDNA-driven tumor progression and therapy resistance. This evidence concerns the gene DNER and neoplasm.